Jeff Simmons serves as president and chief executive officer of Elanco Animal Health. As a global leader with a 65-year track record of growth, Elanco provides comprehensive products and knowledge services to improve animal health, welfare and food animal production with 125 brands in 90 countries.
Jeff is a purpose-driven leader with nearly 30 years of experience delivering business results, engaging employees and developing the next generation of leaders. Jeff has directed the company’s transformation to a premier global player with a balanced and diversified business, having completed 12 acquisitions and built five new businesses, including a $1 billion companion animal business, and a leading aquaculture business. In 2018, Jeff navigated the company’s separation from Eli Lilly and Company, culminating with Elanco’s listing on the New York Stock Exchange as an independent public company solely dedicated to animal health. Most recently, he has orchestrated the company’s acquisition of companion animal start-up Aratana and the pending acquisition of Bayer Animal Health.
During his time with the company, Jeff has gained perspective on food and companionship that sparked a deep conviction for the power of healthy animals, and created a vision for Elanco centered on Food and Companionship Enriching Life
Healthier animals are the key to solving some of the world’s most pressing issues, such as food security and nutrition, human health and well-being, and environmental sustainability. Animals are the x-factor the world has been looking for – the game-changing variable that will unlock solutions to these seemingly disconnected issues of physical, mental and environmental health.
Jeff brings his passions for food security and enabling leaders to life daily through his pursuits with HATCH for Hunger™ and Edge Mentoring. As the co-founder of HATCH, Jeff and the team have created a unique model to sustainably deliver eggs to food banks across the country. Jeff also founded Edge Mentoring, one of the fastest-growing mentorship organizations in the country, designed to equip and accelerate whole-life excellence in leaders.
Simmons has also held a number of leadership positions, including serving as a former board member and chairman of the compensation committee for Chiquita Brands. He has completed terms as president of the Health for Animals, chairman of the FFA Foundation Board and as a board member of Gleaners Food Bank of Indiana.
What is Jeffrey N. Simmons' net worth?
The estimated net worth of Jeffrey N. Simmons is at least $1.69 million as of August 12th, 2024. Mr. Simmons owns 145,000 shares of Elanco Animal Health stock worth more than $1,686,350 as of December 21st. This net worth evaluation does not reflect any other assets that Mr. Simmons may own. Additionally, Mr. Simmons receives an annual salary of $2,460,000.00 as President & CEO at Elanco Animal Health. Learn More about Jeffrey N. Simmons' net worth.
How old is Jeffrey N. Simmons?
What is Jeffrey N. Simmons' salary?
How do I contact Jeffrey N. Simmons?
Has Jeffrey N. Simmons been buying or selling shares of Elanco Animal Health?
Jeffrey N. Simmons has not been actively trading shares of Elanco Animal Health during the last quarter. Most recently, on Monday, August 12th, Jeffrey N. Simmons bought 100,000 shares of Elanco Animal Health stock. The stock was acquired at an average cost of $13.01 per share, with a total value of $1,301,000.00. Following the completion of the transaction, the chief executive officer now directly owns 145,000 shares of the company's stock, valued at $1,886,450. Learn More on Jeffrey N. Simmons' trading history.
Who are Elanco Animal Health's active insiders?
Are insiders buying or selling shares of Elanco Animal Health?
During the last year, Elanco Animal Health insiders bought shares 4 times. They purchased a total of 138,500 shares worth more than $1,930,475.00. The most recent insider tranaction occured on August, 22nd when Director Michael J Harrington bought 3,500 shares worth more than $51,975.00. Insiders at Elanco Animal Health own 0.6% of the company.
Learn More about insider trades at Elanco Animal Health. Information on this page was last updated on 8/22/2024.